US EditionPublished • loading... • Updated
Venus Remedies Shares Jump After Indonesia Marketing Approval
Mumbai, January 9: (Udaipur Kiran). Shares of Venus Remedies Ltd surged on Friday after the company received marketing authorisation in Indonesia for its antibiotic combination Ceftazidime + Avibactam. The stock was trading at ₹727.00 on the BSE, up ₹15.75 or 2.21 percent from its previous close of ₹711.25. It opened at ₹682.00 and touched an intraday high of ₹727.00 and a low of ₹682.00. A total of 666 shares were traded during the session. The…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Venus Remedies Shares Jump After Indonesia Marketing Approval
Mumbai, January 9: (Udaipur Kiran). Shares of Venus Remedies Ltd surged on Friday after the company received marketing authorisation in Indonesia for its antibiotic combination Ceftazidime + Avibactam. The stock was trading at ₹727.00 on the BSE, up ₹15.75 or 2.21 percent from its previous close of ₹711.25. It opened at ₹682.00 and touched an intraday high of ₹727.00 and a low of ₹682.00. A total of 666 shares were traded during the session. The…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
